SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy

Clinical trial NCT04931979 · UNKNOWN

Trial details

NCT number: NCT04931979
Sponsor: Prof. Dr. med. Christian Gratzke
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Urologic Cancer Biochemical Recurrence of Malignant Neoplasm of Prostate

Start date: 2022-10-20
Primary completion: 2025-07-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.